Rachel McMinn
2014
In 2014, Rachel McMinn earned a total compensation of $2.8M as Chief Strategy and Business Officer at Intercept Pharmaceuticals.
Compensation breakdown
| Bonus | $130,169 |
|---|---|
| Option Awards | $1,166,901 |
| Salary | $236,667 |
| Stock Awards | $1,300,263 |
| Other | $2,560 |
| Total | $2,836,560 |
McMinn received $1.3M in stock awards, accounting for 46% of the total pay in 2014.
McMinn also received $130.2K in bonus, $1.2M in option awards, $236.7K in salary and $2.6K in other compensation.
Rankings
In 2014, Rachel McMinn's compensation ranked 3,212th out of 13,032 executives tracked by ExecPay. In other words, McMinn earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,212 out of 13,032 | 75th |
Division Manufacturing | 1,142 out of 4,965 | 77th |
Major group Chemicals And Allied Products | 368 out of 1,690 | 78th |
Industry group Drugs | 287 out of 1,369 | 79th |
Industry Pharmaceutical Preparations | 235 out of 1,042 | 77th |
Source: SEC filing on June 20, 2016.
McMinn's colleagues
We found four more compensation records of executives who worked with Rachel McMinn at Intercept Pharmaceuticals in 2014.